List View

Displaying 1 - 25 of 2,438

B-Cell NHL (Low-Grades)

B-Cell NHL (Aggressive) - Relapsed (CAR T versus Bispecifics?)

Myelodysplasia: De Novo and Acquired- What To Do?

Acute Myeloid Leukemia

Chronic Lymphocytic Leukemia

Updates in Waldenstrom’s Macroglobulinemia

Novel Advances in Multiple Myeloma as Front-Line Therapy

New Platforms and Developments of Immunotherapy Biomarkers Beyond PD-L1 in Tissue?

Small Cell Lung Cancer

Bi-Specific Inhibitor & ADC in Lung Cancer

Immunotherapy in NSCLC: First Line for Advanced Disease

Front Line Targeted Therapy in NSCLC: Tyrosine Kinase Inhibitors

Controversies in Breast Cancer: Use of ctDNA to Tailor Systemic Adjuvant / Post-neoadjuvant Therapies (Part 2)

Controversies in Breast Cancer: Use of ctDNA to Tailor Systemic Adjuvant / Post-neoadjuvant Therapies (Part 1)

Controversies in Lung Cancer:<br /> Neoadjuvant vs Adjuvant IO in Early Stage NSCLC

Kidney & Bladder Cancer: Targeted, Immuno & Other Strategies

Prostate Cancer: Diagnostic and Therapeutic Updates

Immunotherapy in Breast Cancer: Now & The Future

HER-2 Disease: Amplification/Overexpression/Mutation in Breast Cancer

Triple Negative Breast Cancer: Optimal Strategies

Endocrine Therapy for Early -and Late- Stages Breast Cancer: Therapeutic Updates

Management of Malignant Hypercalcemia, Bone Metastases & Standard Precautions to Decrease Adverse Events

How to Handle Myelotoxicity from Chemotherapy in 2024: From Colony-Stimulating Factors (CSF) to Agents<br /> Providing Myeloprotection to the Three Cell Lines

What To Do When Patients Getting Immunotherapy Do Not Respond to Steroids<br /> (Hepatitis, Colitis, Pneumonitis, and Others)

Targeted Therapy and Immunotherapy for Soft Tissue Tissue Sarcomas